Condition
Patients with malignant peritoneal mesothelioma
Total Trials
1
Recruiting
0
Active
0
Completed
1
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Intraperitoneal Paclitaxel Solution Ml
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 1/2 (1)
Trial Status
Completed1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Intraperitoneal Paclitaxel Solution Ml1
Active Sponsors
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)1
- Erasmus Medical Center1
Related Conditions
- Peritoneal Malignant Mesothelioma1